Select a community
HIV
Find out more about the PatientsLikeMe
HIV Community
Home > Community Treatment Reports > Reyataz (atazanavir) Treatment Report
What is Reyataz?

Reyataz is a brand name for the drug atazanavir is a protease inhibitor used in combination with other medications to treat human immunodeficiency virus (HIV) in patients with or without acquired immunodeficiency syndrome (AIDS).

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Treat my HIV 73 16
Other 2 0
General health 2 0
disease-related symptoms 1 0
Loss of short term memory 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
1 6%
Moderate
2 13%
Mild
2 13%
None
11 69%

Most commonly reported side effects

Stomach cramps
3 19%
Diarrhea
2 13%
Fatigue
2 13%
Headaches
1 6%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Reyataz. See all 11 dosages ►

  daily 1 daily 2 tbs. daily 3 daily 100 mg daily 150 mg daily 200 mg daily 300 mg daily 400 mg daily 600 mg daily 9000 mg daily
  4 Number of Patients: 4 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 7 Number of Patients: 7 5 Number of Patients: 5 6 Number of Patients: 6 40 Number of Patients: 40 12 Number of Patients: 12 4 Number of Patients: 4 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Reyataz (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
8 50% Side effects too severe: 50%
Other
4 25% Other: 25%
Doctor's advice
2 13% Doctor's advice: 13%
Expense
1 6% Expense: 6%
Not indicated
1 6% Not indicated: 6%

See all 14 patients who’ve stopped taking Reyataz

Duration See details about how long patients take this treatment ▼

Currently Taking Reyataz

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
2
5
8
10
15

Stopped Taking Reyataz

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
3
4
1
2
3

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
16 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
1 6%
A little
3 19%
Not at all
12 75%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
3 19%
$25-49
2 13%
< $25
5 31%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.